NRX Pharmaceuticals, Inc. current report, 09 August 2019

SEC Filing Summary: Big Rock Partners Acquisition Corp.

Business Context and Reporting Period

This Form 8-K was filed by Big Rock Partners Acquisition Corp. (not NRX Pharmaceuticals, Inc.) on August 12, 2019, reporting an event that occurred on August 9, 2019. The registrant is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware, with securities trading on The NASDAQ Stock Market LLC under symbols BRPAU, BRPA, BRPAR, and BRPAW.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory listing status update rather than financial performance.

Material Changes

  • Nasdaq Listing Deficiency: The Company received a notice from the Nasdaq Capital Market stating it no longer meets the requirements for continued listing under Rule 5550(a)(3).
  • Reason for Deficiency: Failure to maintain a minimum of 300 public holders.
  • Current Status: The notice is a notification of deficiency and does not result in immediate delisting or affect current trading.

Outlook, Risks, and Management Commentary

The Company intends to submit a plan to regain compliance with the 300 public holder requirement by September 23, 2019. If Nasdaq accepts the plan, the Company may receive an extension of up to 180 calendar days to evidence compliance. If the plan is rejected, the Company retains the right to appeal the decision before a Nasdaq Hearings Panel. Management notes that actual results may vary due to the uncertainty of submitting a satisfactory compliance plan and achieving the required number of public holders.

Investor Verification Checklist

  • Verify the current number of public holders to assess the severity of the deficiency.
  • Monitor the submission of the compliance plan by the September 23, 2019 deadline.
  • Check for any subsequent announcements regarding Nasdaq's acceptance or rejection of the compliance plan.
  • Review the Company's most recent 10-K or 10-Q for actual financial position data, as this 8-K contains no financial metrics.